MRNA-Based Therapeutics
MRNA-Based Therapeutics, Volume 372 in the International Review of Cell and Molecular Biology series, covers topics surrounding the effect of different metabolic situations, their contribution to metabolic modulation, and their impact on tumor growth....
Leider schon ausverkauft
258.99 €
versandkostenfrei
129 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „MRNA-Based Therapeutics “
Weitere Produktinformationen zu „MRNA-Based Therapeutics “
MRNA-Based Therapeutics, Volume 372 in the International Review of Cell and Molecular Biology series, covers topics surrounding the effect of different metabolic situations, their contribution to metabolic modulation, and their impact on tumor growth. Specific chapters in this release include New era of nucleic acid therapies: Clinical applications and perspectives, Messenger RNA as personalized therapy: time of truth for rare metabolic disease, Applications of Self-Replicating RNA, mRNA therapy in PKU, Advances in gene-editing technologies, mRNA delivery technologies: towards clinical translation, Advances in mRNA vaccines, and more.
Bibliographische Angaben
- Herausgegeben:Aranda Vega, Fernando; Berraondo, Pedro; Galluzzi, Lorenzo
- Verlag: Academic Press
- EAN: 9780323994019
Autoren-Porträt
Fernando Aranda holds a BSc in Biology (2006) and Biochemistry (2007) from the University of Navarra. Then, he specialized in different strategies of Cancer Immunotherapy with a MSc in Biomedical Research (2008), and a PhD Degree (2012) from the University of Navarra (Pamplona) - Cima University of Navarra. More than 12 years in translational research focus on antitumor immune responses and Cancer Immunotherapy. Author of 64 publications indexed in PubMed in prestigious international journals, with h-index 30 and 4,296 cites (October 2022). He completed the Program of Sara Borrell (ISCIII) -competitive Postdoctoral contract- in the Group of Immune Receptors of the Innate and Adaptive System (IDIBAPS), Barcelona (2016-2018). Co-author of 1 invention patent: Composition based on the fibronectin domain A for the treatment of melanoma - WO/2011/101332. In 2012, Fernando Aranda obtained a Scientific Award, "Profesor Durantez" II Edición, for the best scientific article in Tumor Immunology by Fundación LAIR. Recently, Fernando Aranda awarded a competitive Research Fellow contract "Miguel Servet tipo I? by Instituto de Salud Carlos III, to continue his independent researcher career (IP) in cancer immunotherapy issues. Specifically, he is involved in Translational Immunotherapy of Peritoneal Carcinomatosis. Currently, Fernando Aranda leads a research group in cooperation with Dr. Pedro Berraondo.
Inhaltsverzeichnis zu „MRNA-Based Therapeutics “
1. New era of nucleic acid therapies: Clinical applications and perspectives Andoni Garitano 2. Messenger RNA as personalized therapy: time of truth for rare metabolic disease Antonio fontanellas 3. Applications of Self-Replicating RNA Kenneth Lundstrom 4. mRNA therapy in PKU Ramon Diaz Trelles 5. Advances in gene-editing technologies Robert MacLaren and Ruofan Connie Han 6. mRNA delivery technologies: towards clinical translation Maria Angeles Solinis 7. Advances in mRNA vaccines Xiaojun Xia
Kommentar zu "MRNA-Based Therapeutics"
0 Gebrauchte Artikel zu „MRNA-Based Therapeutics“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "MRNA-Based Therapeutics".
Kommentar verfassen